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Nontraumatic lower extremity amputations in the Medicare Medicare ESRD program. This is four times the 15,327
end-stage renal disease population. who began treatment in 1978. In addition, diabetes is
Background. Nontraumatic lower limb amputation is a serious the most common cause of renal failure, accounting forcomplication of both diabetic neuropathy and peripheral vascular
38% of all new cases in 1994, which is up from 17%disease. Many people with end-stage renal disease (ESRD) suffer
from 1978 [1]. The progression of diabetes to end-stagefrom advanced progression of these diseases. This study pres-
ents descriptive information on the rate of lower limb amputa- renal failure is associated with the progression of multiple
tion among people with ESRD who are covered by the Medi- other complications of diabetes, including neuropathy
care program. and peripheral vascular disease [2]. Not uncommonly,Methods. Using hospital bill data for the years 1991 through
lower extremity amputation (LEA) results in the loss of1994 from the Health Care Financing Administration’s ESRD
part of the toe, foot, or leg in the persons being treatedprogram management and medical information system (PMMIS),
amputations were based on ICD9 coding. These hospitaliza- for end-stage renal failure. In addition, problems leading
tions were then linked back to the PMMIS enrollment database to amputations often recur in the ipsilateral or contralat-
for calculation of rates. eral extremity, further impairing mobility and rehabilita-Results. The rate of lower limb amputation increased during
tion from the initial amputation.the four-year period from 4.8 per 100 person years in 1991 to
The pathogenesis of LEA in diabetes is multifactorial.6.2 in 1994. Among persons whose renal failure was attributed
to diabetic nephropathy, the rates in 1991 and 1994 were 11.8 The initial lesions are often initiated by minor trauma
and 13.8, respectively. The rate among diabetic persons with leading to ulcerations, which progress because of the
ESRD was 10 times as great as among the diabetic population combination of ischemia and peripheral neuropathyat large. Two thirds died within two years following the first
complicated by faulty wound healing and gangrene [3–6].amputation.
Diabetic ESRD patients are at high risk for these condi-Conclusions. The ESRD population is at an extremely high
risk of lower limb amputation. Coordinated programs to screen tions. Similar predisposing conditions (that is, peripheral
for high-risk feet and to provide regular foot care for those at neuropathy and vascular disease) exist in ESRD patients
high risk combined with guidelines for treatment and referral who do not have diabetes [7–9]. Many amputations inof ulceration are needed.
diabetic patients are initiated by a potentially prevent-
able event such as minor trauma or ill-fitting footwear.
In a series from the Veterans Administration, suchPrior to the Social Security Amendments of 1972 ex-
events were identifiable in 86% of the diabetic personstending Medicare coverage to persons with end-stage
undergoing amputation [10]. Thus, the diabetic ESRDrenal disease (ESRD), diabetes was a contraindication
patients and those with uremia from other causes are atto treatment for persons in need of dialysis or transplant.
high risk for potentially preventable LEAs.Since that time, the number of treated incident cases of
The epidemiology of LEA has been described in dia-ESRD has risen dramatically. In 1994, there were 62,266
betic populations using hospital discharge records [4, 11].persons who began renal replacement therapy in the
Age-adjusted rates of 8 out of 1000 per year were re-
ported from the National Health Discharge Data in 1990
[12]. Most studies have shown higher rates among malesKey words: diabetic nephropathy, peripheral vascular disease, leg am-
putation, ulceration, gangrene. than among females and significant racial and ethnic varia-
tion with African Americans and Native Americans expe-Received for publication December 14, 1998
riencing higher rates than non-Hispanic whites [4, 12–14].and in revised form May 12, 1999
Accepted for publication May 18, 1999 Mortality is high in follow-up, with a two-year survival
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In a preliminary study, Hill et al identified a higher rate to 1994 period, it is estimated that 2 to 3% of ESRD
beneficiaries belonged to HMOs.of foot problems in diabetic ESRD patients (25%) com-
pared with 10% of diabetic patients who were not receiv- This analysis is based on hospitalizations during 1991
through 1994 during which a lower limb amputation wasing renal replacement therapy [16].
Several intervention studies have been published show- performed. ICD9-CM codes 84.10 through 84.19 were
used to select stays in which an amputation occurred.ing reductions in amputation rates [17–20]. In general,
successful programs have used a multidisciplinary ap- Between 1991 and 1994, there were 24,886 Medicare
ESRD beneficiaries with at least one hospitalization inproach targeting patient education and regular foot care
services to diabetic individuals known to be at high risk which an amputation occurred. Because of multiple am-
putations, there were 35,898 hospitalizations during thesefor lower extremity problems [21–25]. In one case, a
special foot clinic organized for diabetic renal transplant years among ESRD beneficiaries for whom there was at
least one amputation. Although there were 35,898 hospitalpatients reduced gangrene and major amputations in a
group of patients with both diabetes and renal disease stays in which an amputation occurred, a patient could
have received more than one amputation during a single[26]. Because of the growing recognition that the identi-
fication and intervention among high-risk persons may stay.
Amputation rates were calculated based on the numberreduce rates of LEA, this study was undertaken to exam-
ine the rates of LEA among the Medicare ESRD popula- of ESRD persons ever enrolled during a year. A logistic
regression analysis was performed to estimate the inde-tion. This article describes variation among population
subgroups, recent trends in amputation, and postamputa- pendent effects of demographic variables on the proba-
bility of amputation. The analyses were limited to per-tion mortality.
sons for whom Medicare is the primary payer of services.
For patients with other health insurance, Medicare is the
METHODS
secondary payer of medical care for the first 18 months
Data for this study were obtained from the ESRD following renal failure. HCFA does not receive hospital-
Program Management and Medical Information System ization records for these patients; therefore, they were
(ESRD-PMMIS) maintained by the Office of Clinical excluded from the analyses. (During 1991 through 1994,
Standards and Quality at the Health Care Financing Medicare was the secondary payer for approximately
Administration (HCFA). The ESRD-PMMIS is a longi- 15% of all Medicare ESRD beneficiaries.) Survival was
tudinal file of patients with ESRD who are entitled to calculated using standard life table estimates with right
Medicare benefits. In addition to the basic enrollment censoring for end of observation (May 1996). To control
data available for all Medicare beneficiaries such as sex, for confounding effects of age and treatment status, a
race, date of birth, date of death, and entitlement dates, multivariate proportional hazards model was constructed.
the PMMIS contains information unique to ESRD bene-
ficiaries. The medical evidence form (HCFA 2728) is used
RESULTSto determine date and cause of renal failure. Since July
Descriptive characteristicsof 1994, kidney transplant data have been collected by
the Organ Procurement and Transplant Network (OPTN) Table 1 shows the demographic characteristics of the
and are routinely forwarded to HCFA. Prior to that time, persons included in this study. Also shown in Table 1 are
transplant data were collected through the HCFA 2745. the demographic characteristics of the Medicare-prevalent
The ESRD-PMMIS file used in this study was updated ESRD population as of December 31, 1994, including
through May 1996. This update of the ESRD-PMMIS both dialysis and functioning graft patients. Amputees
contained 706,952 people, the complete count of Medi- were older and much more likely to have diabetes than
care ESRD patients ever entitled since 1978. the overall ESRD population (68.2 vs. 29.1%).
In addition to entitlement records, HCFA receives Table 2 shows the level of the amputation for all hospi-
bill data on all ESRD persons served by fee-for-service talizations included in this study. The 24,886 patients
providers. Hospitalization data include the principal di- accounted for 35,898 amputations. The two most com-
agnosis for the inpatient stay and up to 10 additional mon sites of initial amputation were other amputation
comorbid or complicating conditions. In addition, the below the knee (38.5%) and amputation of toe (27.4%).
hospitalization data include up to six procedures. Coding Table 2 also shows the level of amputation by cause of
for both the diagnoses and procedures are based on the renal failure. Persons whose renal failure was attributed
International Classification of Diseases version 9, current to diabetic nephropathy were less likely to have had an
modification (ICD9-CM). Medicare pays for ESRD ben- amputation above the knee (18.1%) than were people
eficiaries who belong to risk-based managed care organi- whose renal failure was attributed to other causes (25.3%).
zations on a monthly capitation basis and does not re- In subsequent analyses, amputations were grouped into
three categories: (a) toe amputations (code 84.11), (b)ceive hospitalization data for these persons. In the 1991
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Table 1. Demographic characteristics of ESRD amputation patients of amputation was 4.3 per 100 persons. This ranged from
and total ESRD population during 1991 to 1994
4.9 among persons on dialysis to 1.5 for persons receiving
ESRD a transplant. Although the transplant group is younger,
amputation Total Medicare
rates of amputation are higher for the dialysis group inpopulation ESRD population
every age strata except under 15 years. Subsequent tablesPersons Percent Persons Percent
and figures (except for the tables on mortality) show
All persons 24,886 100.0% 232,193 100.0%
amputation rates for the dialysis population only.Age
Under 15 years 1 0.0 1,769 0.8 Figure 1 displays time trends for annualized amputa-
15–24 years 28 0.1 6,039 2.6 tions per 100 persons on dialysis, by year for diabetic
25–34 years 823 3.3 19,545 8.4
and nondiabetic ESRD separately. In 1991, the rate of35–44 years 2,343 9.4 34,208 14.7
45–54 years 4,039 16.2 40,433 17.4 amputation among diabetic patients on dialysis was 11.8
55–64 years 6,369 25.6 44,767 19.3 per 100. This increased each subsequent year up to 13.865–74 years 7,958 32.0 53,816 23.2
per 100 in 1994. Amputation rates for all other dialysis75 years or over 3,325 13.4 31,616 13.6
Sex patients were approximately one fifth as great as for
Male 13,343 53.6 125,983 54.3
diabetic patients, but also showed an increasing rate dur-Female 11,543 46.4 106,210 45.7
Race ing the period of 1991 through 1994. Increasing rates
Asian 365 1.5 5,644 2.4 with time were seen in the majority of age, sex, and raceAfrican American 8,289 33.3 75,574 32.5
strata (data not shown).White 15,345 61.7 143,359 61.7
Native American 553 2.2 2,841 1.2 Figure 2 displays LEA incidence by age for diabetic
Other/unknown 334 1.3 4,775 2.1 and all other ESRD. Those aged 45 to 54 years had thePrimary diagnosis
Diabetes 16,974 68.2 67,460 29.1 highest rate among diabetic ESRD patients. The peak
Glomerulonephritis 884 3.6 36,859 15.9 incidence was older (55 to 64 years of age) for all other
Hypertension 4,062 16.3 58,189 25.1
ESRD.Cystic kidney disease 201 0.8 9,228 4.0
Interstitial nephritis 246 1.0 7,626 3.3 Figure 3 displays the rates by race. The lowest rates
Obstructive nephropathy 171 0.7 4,890 2.1 were found for Asian beneficiaries, and the highest ratesOther 375 1.5 15,927 6.9
were found for Native Americans among diabetic ESRD.Unknown 715 2.9 13,097 5.6
Not reported 1,258 5.1 18,917 8.1 In contrast to the general population, Caucasians have
higher LEA rates than African Americans. Among all
other ESRD patients, the other/unknown race category
had the highest rates of LEA, but African Americansall other below-knee amputations (codes 84.12 through
were a close second (2.8 vs. 2.7). The lowest rates were84.15), and (c) all above-knee amputations (codes 84.16
again among Asian beneficiaries.through 84.19).
Because the presence of diabetes varies considerablyTable 3 shows the principal diagnosis associated with
across racial and age groups, the bivariate analyses ineach amputation stay. Over 40% of the stays had diabe-
tes mellitus listed as the principal diagnosis. Of these, Table 4 and Figures 1 to 3 may not adequately show the
82% (or 33.2% of all hospital stays) had diabetes with relative rates across demographic groups. Table 5 shows
peripheral circulatory disease as the principal diagnosis a multivariate analysis of the hospitalization rate for
(data not shown). The second most common diagnosis amputation. There was a steep gradient in the probability
was atherosclerosis (18.5%), followed by gangrene with of hospitalization with increasing age up to ages 65 to
7.1% of cases. However, gangrene was listed as either 74. Males were 23% more likely to have an amputation
the principal or secondary diagnosis in two thirds of all than were females. Compared with whites, amputation
the amputations (data not shown). For persons whose was 6% greater among blacks and 28% greater among
renal failure was attributed to diabetic nephropathy, dia- Native Americans. Asian Americans were only 58% as
betes mellitus was the principal diagnosis in almost one
likely to get an amputation as were whites. Persons
half of the amputations. For persons whose renal failure
whose renal failure was caused by diabetes were almostwas not attributed to diabetes, diabetes was still the
nine times as likely to get an amputation as were personsprincipal diagnosis in almost one fourth of the amputa-
with glomerulonephritis. Rates were also higher for per-tions. Hypertension and atherosclerosis are often comor-
sons with hypertension and an unknown or not reportedbid with diabetes and may explain the lack of concur-
cause of renal failure. The higher rates for the latter tworence between the cause of LEA and the cause of ESRD.
categories could be due to comorbid diabetes. Finally,
Amputation rates persons who received a transplant and persons with a
functioning graft were only 37 and 77% as likely to getTable 4 shows the amputation rates for the ESRD
population in 1994 by treatment status. The overall rate an amputation as were persons on dialysis.
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Table 2. Level of lower limb amputation Medicare ESRD patients during 1991 to 1994
Cause of renal failure
All persons Diabetic nephropathy All other causes
ICD9-CM Location N (%)
Total 35,898 (100.0) 25,037 (100.0) 10,861 (100.0)
84.10 Lower limb amputation, not otherwise specified 23 (0.1) 16 (0.1) 7 (0.1)
84.11 Amputation of toe 9,830 (27.4) 7,051 (28.2) 2,779 (25.6)
84.12 Amputation through foot 4,387 (12.2) 3,172 (12.7) 1,215 (11.2)
84.13 Disarticulation of ankle 73 (0.2) 60 (0.2) 13 (0.1)
84.14 Amputation of ankle thorugh malleoli of tibia and fibula 244 (0.7) 180 (0.7) 64 (0.6)
84.15 Other amputation below knee 13,835 (38.5) 9,885 (39.5) 3,950 (36.4)
84.16 Disarticulation of knee 163 (0.5) 110 (0.4) 53 (0.5)
84.17 Amputation above knee 7,275 (20.3) 4,523 (18.1) 2,752 (25.3)
84.18 Disarticulation of hip 66 (0.2) 38 (0.2) 28 (0.3)
84.19 Abdominopelvic amputation 2 2 0 (*)
Data are: Number of hospitalizations (percent). Diabetic patients are defined as those whose renal failure was attributed to diabetes. The other patients may have
diabetes but their renal failure was not attributed to diabetes.
Table 3. Principal diagnoses for amputations in Medicare ESRD beneficiaries
Cause of renal failure
All LEA persons Diabetic nephropathy All other
ICD9 causes Diagnosis N (%)
All hospitalizations 35,898 (100.0) 25,037 (100.0) 10,861 (100.0)
038 Septicemia 1,059 (3.0) 741 (3.0) 318 (2.9)
250 Diabetes mellitus 14,539 (40.5) 12,019 (48.0) 2,520 (23.2)
440 Atherosclerosis 6,650 (18.5) 3,690 (14.7) 2,960 (27.3)
443 Other peripheral vascular disease 1,276 (3.6) 644 (2.6) 632 (5.8)
444 Arterial embolism and thrombosis 1,015 (2.8) 504 (4.6) 511 (2.0)
682 Other cellulitis and abscess 445 (1.2) 329 (1.3) 116 (1.1)
707 Chronic ulcer of skin 794 (2.2) 497 (2.0) 297 (2.7)
730 Osteomyelitis, periostitis, and other infections
involving bone 1,414 (3.9) 1,057 (4.2) 357 (3.3)
785 Symptoms involving cardiovascular system
including gangrene 2,548 (7.1) 1,546 (6.2) 1,002 (9.2)
996 Complications peculiar to certain specified
procedures including grafts 1,239 (3.5) 745 (3.0) 494 (4.5)
997 Complications affecting specified body systems
(including amputation stump complication) 1,487 (4.1) 1,109 (4.4) 378 (3.5)
All other 3,350 (9.3) 2,067 (8.3) 1,283 (11.8)
Diabetic patients are defined as those whose renal failure was attributed to diabetes. The other patients may have diabetes but their renal failure was not attributed
to diabetes.
Mortality for the entire ESRD dialysis population from the date
of renal failure are 78.7% at one year and 63.2% at twoTable 6 shows the cumulative survival following the
years (HCFA, 1997).first amputation. [Note that this is actually the first ampu-
Age had a strong effect on postamputation survival.tation following renal failure, during the 1991 through
The two-year survival for persons under age 25 was over1994 time period and after Medicare became the primary
60%. This declined to 15.8% among persons aged 75payer. Amputations that occurred (a) prior to 1991, (b)
and over. Males had slightly higher survival rates thanand/or prior to renal failure, (c) and/or during a period
did females. By racial category, two-year postamputationwhen Medicare was the secondary payer will have been
survival rates ranged from a low of 27.4% among Asianmissed. Tracking patients prior to their Medicare entitle-
beneficiaries to a high of 39.1% among Native Americanment date is not possible in the Medicare database. Of
beneficiaries.those patients who received an amputation after renal
Interestingly, persons whose renal failure was attrib-failure, 3% had at least one amputation prior to renal
uted to diabetes have a somewhat better survival followingfailure.] The survival at 30 days postamputation was
amputation than do other persons. At two years postam-88.9%. At one year, the survival rate was 49.3%, and at
two years, it was 32.7%. In comparison, survival rates putation, there is an approximate 6 to 10% differential in
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Table 4. Hospitalizations for amputation among ESRD beneficiaries by age, sex, race, and diagnosis by treatment category during 1994
All persons Dialysis Transplant Functioning graft Graft failure
(N 5 239,170) (N 5 190,147) (N 5 6,408) (N 5 40,702) (N 5 1,913)
Number of discharges per 100 persons
All persons 4.3 4.9 1.5 2.0 3.0
Age
Under 15 years 0.1 0.2 0.3 0.1 0.0
15–24 years 0.6 0.7 0.4 0.4 0.6
25–34 years 2.3 2.4 1.8 2.1 3.1
35–44 years 3.3 3.8 1.7 2.5 2.5
45–54 years 5.4 6.2 2.1 2.9 7.3
55–64 years 6.2 6.8 1.8 2.1 2.8
65–74 years 5.3 5.4 0.8 1.2 16.0
75 years or over 3.1 3.1 0.0 0.0 0.0
Sex
Male 4.4 5.0 1.8 2.4 3.3
Female 4.2 4.7 1.1 1.5 2.5
Race
Asian 3.0 3.9 1.0 0.1 0.0
African American 4.5 5.0 1.2 1.7 1.3
White 4.1 4.8 1.7 2.2 4.0
Native American 8.2 9.1 4.4 4.2 0.0
Other/unknown 3.8 4.2 1.0 0.5 10.5
Primary diagnosis
Diabetes 10.0 10.4 3.0 7.6 12.4
Glomerulonephritis 0.9 1.2 0.3 0.3 0.0
Hypertension 2.6 2.8 0.4 0.5 1.5
Cystic kidney disease 0.7 1.0 0.0 0.4 1.3
Interstitial nephritis 1.3 1.6 0.0 0.3 0.0
Obstructive nephropathy 1.0 1.2 0.8 0.4 0.0
Other 0.9 1.1 13.9 0.3 0.0
Unknown 1.8 2.2 0.8 0.4 1.3
Not reported 3.3 3.8 0.0 1.8 2.6
Excludes Medicare secondary payer patients.
above-the-knee amputation patients. The diabetic sur-
vival advantage may be partially explained by the fact
that diabetic patients on average had amputations at
lower levels (Table 2).
The treatment status at the time of amputation was
also associated with postamputation survival. Persons on
dialysis who had never received a transplant had the
worst survival rate (28.1% at two years). Persons who
were on dialysis following a failed transplant did slightly
better at 36.0%. Persons with a functioning transplant
at the time of amputation did much better, with a two-
year survival rate of 75.6%.
It is highly likely that some of these differences are
due to selection effects. For example, both the function-
ing graft patients and the dialysis patients with a failedFig. 1. Time trends in annualized lower extremity amputation (LEA)
incidence by diabetes mellitus (r) and all other causes (j). transplant are significantly younger than the average di-
alysis patient. Therefore, in order to help control for
confounding effects of these variables on survival, a mul-
tivariate proportional hazards model was constructed.favor of diabetic persons compared with persons whose
The results are displayed in Table 7 as relative risk ratios.renal failure was due to other factors.
In general, the univariate results shown in Table 6Not surprisingly, the extent of the initial amputation
were consistent with the multivariate results in Table 7.was strongly associated with subsequent mortality. A
There was a strong age effect. Persons under the age oftwo-year survival for persons whose initial amputation
25 had one half (52%) of the mortality of persons agedwas the toe was 44.8%. This decreased to 31.7% for
amputations below the knee and to only 15.2% for 45 to 54, whereas the mortality rate was 81% greater for
Eggers et al: Lower extremity amputations in ESRD 1529
Fig. 2. Annualized LEA by age strata for dia-
betes mellitus (j) and all other causes (h) in
1994.
Table 5. Patient hospitalization for amputation: Odds ratio model
Variable Comparison Odds ratio P value
Ages
0 to 14 Ages 45 to 54 — NS
15 to 24 Ages 45 to 54 0.04 ,0.0001
25 to 34 Ages 45 to 54 0.52 ,0.0001
35 to 44 Ages 45 to 54 0.79 ,0.0001
55 to 54 Ages 45 to 54 1.07 0.0579
65 to 74 Ages 45 to 54 1.14 0.0004
75 and over Ages 45 to 54 — NS
Gender
Male Female 1.23 ,0.0001
Race
African American White 1.06 0.0002
Native American White 1.28 0.0022
Asian White 0.58 0.0001
Other/unknown race White — NS
Fig. 3. Annualized incidence of LEA by race in 1994. Symbols are: Primary diagnosis
(j) diabetes mellitus; (h) non-diabetes mellitus. Diabetes Glomerulonephritis 8.93 ,0.0001
Hypertension Glomerulonephritis 2.11 ,0.0001
CKD Glomerulonephritis — NS
Interstitial Glomerulonephritis — NS
Nephropathypersons over age 75. Males had a 6% lower mortality rate
Obstructive Glomerulonephritis — NSthan did females. Mortality was 32% lower for African Nephropathy
Americans and 26% lower for Native Americans than Other Glomerulonephritis — NS
Unknown Glomerulonephritis 1.83 ,0.0001for whites. Compared with persons whose renal failure
Not reported Glomerulonephritis 2.24 ,0.0001was attributed to glomerulonephritis, persons with dia- Kidney status
betes had an 11% lower mortality rate, and persons with Transplant Dialysis (never Tx) 0.37 ,0.0001
Functioning Graft Dialysis (never Tx) 0.77 ,0.0001obstructive nephropathy had a 27% lower mortality rate.
As expected, the extent of the original amputation
had a significant effect on subsequent mortality. Com-
pared with toe amputations, persons with below-the-
knee amputations had a 37% greater mortality rate, on dialysis. There was no difference in mortality between
whereas persons with above the knee amputations had persons on dialysis who had never been transplanted
a more than twice the mortality rate. Gangrene, either and those who had lost a transplanted kidney.
as a principal diagnosis or a secondary diagnosis, was
associated with a 10% increase in postamputation mor-
DISCUSSIONtality.
Treatment for ESRD identifies a group of patients atFinally, persons with a functioning kidney transplant
had one third the postamputation mortality of persons very high risk for lower extremity problems. To our
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Table 6. Cumulative survival following first amputation after renal failure for Medicare ESRD patients during 1991 through 1994
Days postamputation
N 30 60 90 182 365 730
All persons 24,877 88.9% 80.1% 74.2% 62.8% 49.3% 32.7%
Age
0 to 24 29 86.2 86.2 86.2 79.3 69.0 65.0
25 to 34 419 96.4 93.2 89.7 83.0 73.8 61.3
35 to 44 2,342 95.8 91.3 88.0 78.6 67.3 53.3
45 to 54 4,038 93.8 88.0 84.0 74.1 60.7 44.0
55 to 64 6,365 90.2 82.0 76.5 65.1 51.3 33.1
65 to 74 7,956 86.0 75.7 68.7 56.5 41.7 24.5
75 and over 3,324 80.4 66.3 57.0 43.9 30.9 15.8
Gender
Male 13,339 89.4 81.1 75.7 64.9 51.5 35.0
Femlae 11,538 88.3 78.9 72.4 60.5 46.7 29.9
Race
Asian 363 89.0 79.9 73.6 63.4 47.1 27.4
African American 8,287 90.0 81.9 76.3 66.6 54.1 37.3
Native American 553 93.1 85.9 80.8 70.9 59.7 39.1
Other/unknown 333 91.0 82.3 77.2 68.2 49.6 35.3
White 15,341 88.1 79.9 72.7 60.4 46.4 30.0
Primary diagnosis
Diabetes 16,970 90.5 82.4 76.7 65.7 51.7 34.8
Glomerulonephritis 892 83.7 74.3 66.8 54.6 41.3 27.8
Hypertension 4,059 84.7 73.7 66.6 55.3 42.3 26.2
Cystic kidney disease 201 79.1 69.7 62.7 50.3 41.8 26.0
Interstitial nephritis 246 82.9 74.0 69.1 53.3 39.0 23.4
Obstructive nephritis 170 88.2 77.1 71.8 61.2 48.2 32.0
Other 363 84.6 75.2 70.5 55.4 44.9 29.2
Unknown 718 85.9 75.4 68.0 55.6 42.9 25.6
Not reported 1,258 89.4 81.3 77.0 64.9 52.5 36.5
Amputation
Toe 7,806 95.2 89.8 85.4 75.8 63.0 44.8
Below knee 12,380 89.6 81.0 75.2 63.2 49.0 31.7
Above knee 4,691 76.3 61.3 52.7 40.3 27.1 15.2
Kidney status
Dialysis (nev tx) 21,898 87.8 78.3 71.9 59.7 45.4 28.1
Functioning graft 2,277 98.3 96.4 95.0 91.4 85.3 75.6
Dialysis (tx fail) 702 92.6 84.1 78.1 66.5 52.4 36.0
knowledge, this is the first report documenting the dis- Among the entire population of diabetic patients, the
proportionate burden of LEA among ESRD patients. relative risk of LEA has ranged from 15 to 24 times
Medicare beneficiaries 65 years of age and older experi- that of the nondiabetic patient [29–31]. Several previous
enced over 65,500 discharges from short-stay hospitals in reports identified the association of foot ulcers and am-
1994 during which LEA was performed. ESRD patients putation in diabetic patients with documented renal dis-
comprised only 0.3% of Medicare beneficiaries in this ease. Among older onset diabetic patients in Wisconsin,
age group but over 6% of the hospitalizations in this age the relative risk of amputation in the diabetic patients
group. Two previous reports estimated the overall rates with proteinuria was 2.7 (95% CI, 1.3 to 5.5) compared
of LEA in the general population at 0.72 out of 10,000 with diabetic patients who did not have proteinuria [32].
person years in Rochester, Minnesota, and 1.6 out of The relative risk (3.9) for LEA with proteinuria was even
10,000 nondiabetic population in New Jersey for the higher (95% CI, 2.2 to 7.0) for the younger onset diabetic
three-year period of 1985 through 1987 [27, 28]. The individuals [32]. Among diabetic Pima Indians, protein-
age structure of the ESRD population, however, is very
uria was associated with a similar risk ratio for LEA ofdifferent from the general population so that direct com-
2.2 (95% CI, 1.4 to 3.6) [33]. A recent case control studyparisons may be misleading. The age-specific rate for the
among Pima Indians reported a relative risk of 5.1 (95%nondiabetic population in New Jersey aged 65 and over
CI, 1.4 to 18) for LEA among diabetic persons with renalwas 9.3 out of 10,000 for the three-year period, and
failure as defined by treatment for ESRD, transplant, oralthough not strictly comparable, the annualized rate of
a serum creatinine of greater than 4 mg/dl [34].2.3 out of 100 hospital discharges per year found in this
The actual rates of LEA among diabetic persons re-study for nondiabetic ESRD patients is likely much
ceiving treatment for ESRD are not easily comparedhigher than LEA rates found among the oldest nondia-
betic individuals who have the highest rates of LEA [28]. with other published rates of LEA in diabetic patients,
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Table 7. ESRD patient mortality following first amputation after amputations (39%) compared with diabetic patients in
renal failure: Cox proportional hazards model
the National Hospital Discharge Survey data from 1989
Relative to 1992 (25%) [35]. For the nondiabetic patients, the
Variable Comparison Risk P value proportion of above-knee amputations (39%) was higher
Age in the general population compared with the nondiabetic
0 to 24 Ages 45 to 54 0.52 ,0.0196
ESRD population (25%) [4].25 to 34 Ages 45 to 54 0.68 ,0.0001
35 to 44 Ages 45 to 54 0.85 ,0.0001 Mortality reported in a one-year follow-up for all dia-
55 to 64 Ages 45 to 54 1.17 ,0.0001 betic patients after LEA varied from 60 to 70% de-
65 to 74 Ages 45 to 54 1.38 ,0.0001
pending on the series [4, 15]. The lower survival of 50%75 and over Ages 45 to 54 1.81 ,0.0001
Gender among all the ESRD patients at one year after amputa-
Male Female 0.94 ,0.0001 tion is not surprising in view of the overall morbidity
Race
and mortality in ESRD patients. Similarly, perioperativeBlack White 0.68 ,0.0001
Native American White 0.74 ,0.0001 mortality (death within 30 days) among diabetic patients
Asian White — NS with LEA in the United States averaged 5.8% between
Other/unknown White 0.85 0.0089
1989 and 1992 compared with a 30-day cumulative mor-Primary diagnosis
Diabetes Glomerulonephritis 0.89 ,0.0036 tality of 11% in the ESRD patients [36].
Hypertension Glomerulonephritis — NS In addition to increasing mortality, the morbidity and
CKD Glomerulonephritis — NS
costs associated with potentially preventable LEA inInterstitial nephritis Glomerulonephritis — NS
Obstructive nephropathy Glomerulonephritis 0.73 ,0.0010 ESRD patients are high [4, 37, 38]. The potential for full
Other Glomerulonephritis 0.85 ,0.0207 rehabilitation following amputation is poor in ESRD
Unknown Glomerulonephritis — NS
patients compared with other amputees, and the lossNot reported Glomerulonephritis — NS
Amputation of independence may necessitate institutional care [4].
Below knee Toe 1.37 ,0.0001 Thus, every effort should be made to avoid amputation
Above knee Toe 2.23 ,0.0001
in ESRD patients.Complication
Gangrene No gangrene 1.09 ,0.0001 The risk factors for LEA have been well described and
Kidney status include a readily identifiable loss of protective sensation,
Functional graft Dialysis (never Tx) 0.32 ,0.0001
which puts patients at risk for neuropathic ulcerationFailed graft Dialysis (never Tx) — NS
from repetitive stress or minor trauma [4, 6, 22, 39, 40].
Because of the loss of protective sensation, individuals
ignore early lesions and inadvertently wear damaging
footwear because they experience no pain from the in-because the age structure of the overall diabetic popula-
tion is likely to be different from the age structure of jury [39]. Although neuropathy and peripheral vascular
disease may be more severe among diabetic ESRD pa-the diabetic ESRD group. In addition, the analyses we
report here are somewhat limited by Medicare payment tients, uremia from any cause is associated with both of
these major risk factors for LEA [2, 7, 8]. In addition,policy. Amputations that occur during periods when
Medicare is the secondary payer are missed by our study; healing can be significantly impaired in ESRD patients
[41], and surgical grafting to increase peripheral bloodthe extent of this bias is unknown. However, the annu-
alized rates of 13.8 per 100 hospital discharges reported flow has not been uniformly successful in this population
[42, 43]. Because of the nature of neuropathy, at-riskin this study are higher than the highest age-specific rates
published for any group of diabetic patients [4, 11, 12]. individuals will not necessarily report foot problems at
an early stage and require visual inspection by others toIn New Jersey, the diabetic patients aged 65 and above
experienced rates of amputation of 1049 per 10,000 for detect early, treatable lesions. However, over a six-month
period, simple foot examinations were reported to occurthe period of 1985 to 1987 [28]. In the Netherlands in
1991, the rate of LEA among diabetic persons 75 years of in only 28% of patients undergoing dialysis (abstract;
Levy et al, Diabetes 46:184A, 1997).age and older was 107.9 out of 10,000, and in California, it
was slightly less than 100 per 10,000 when comparable Methods to decrease the incidence of ulceration and
amputation and to promote healing in diabetic patientsrates of amputation were displayed for the oldest age
group during the same time period [31]. have been reported in the literature [5, 17, 19–21, 23, 26, 44].
A well-designed clinical trial showed a reduction in lowerRisk factors for LEA in the diabetic ESRD patients
found in this study are consistent with other studies extremity clinical abnormalities among diabetic patients
when interventions for patient education in foot care wereamong diabetic populations that show excess rates in
males compared with females and high rates among Native combined with guidelines and instruction for their health-
care providers [45]. Coordinated programs to screen forAmericans, African Americans, and Hispanics [4, 11–14].
The distribution of amputation sites for the diabetic high-risk feet and to provide regular foot care for those
at high risk combined with guidelines for treatment andESRD patients showed proportionally more below-knee
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8. Nielsen VK: The peripheral nerve function in chronic renal failure.referral of ulceration reduced LEA rates in several Ameri-
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